A 133 (Bupropion Hydrochloride Extended Release (SR) 150 mg)
Pill with imprint A 133 is Yellow, Round and has been identified as Bupropion Hydrochloride Extended Release (SR) 150 mg. It is supplied by Actavis.
Bupropion is used in the treatment of major depressive disorder; depression; smoking cessation; seasonal affective disorder and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A 133
Bupropion Hydrochloride Extended Release (SR)
- Imprint
- A 133
- Strength
- 150 mg
- Color
- Yellow
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous antidepressants, Smoking cessation agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis
- Inactive Ingredients
-
copovidone,
silicon dioxide,
hydroxypropyl cellulose,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
titanium dioxide,
triacetin,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 67767-0133 (Discontinued) | Actavis Pharma, Inc. |
| 16714-0335 (Discontinued) | NorthStar Rx LLC |
| 53002-1345 | Pharmedix (repackager) |
Related images for "A 133"
More about bupropion
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2,578)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: miscellaneous antidepressants
Patient resources
- Drug Information
- Bupropion (Advanced Reading)
- Bupropion Extended-Release Tablets
- Bupropion Sustained-Release Tablets (Smoking Deterrent)
- Bupropion Tablets and Sustained-Release Tablets
- Other brands
- Wellbutrin, Wellbutrin XL, Wellbutrin SR, Zyban, ... +5 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.